Growth opportunity Target mid-sized pharmaceutical manufacturers with revenue in the $1M–$10M range for tailored value propositions around scalable cloud-based IT and analytics to support GMP compliance, batch tracking, and supply chain transparency.

Listing and finance Leverage Bayview Acquisition Corp background to position offering around capital-efficient tech investments, risk-managed cloud infrastructure, and data-driven operations as a means to accelerate post-merger growth for shell/SPAC-adjacent pharma entities.

Digital uptime Emphasize security and reliability tooling from existing tech stack (Cloudflare Bot Management, Google Cloud, CDN, Analytics) to appeal to pharma firms prioritizing regulatory-compliant, resilient web and data services for patient-facing portals and supplier integrations.

Analytics readiness Offer analytics and marketing tech optimization packages that complement current tools (Google Analytics, Comscore, Tailwind CSS, Office 365) to enhance market intelligence, KOL outreach, and product launch tracking for small-to-midsize pharma players.

Partnership fit Position as a scalable partner for firms in the same revenue band and headcount as Baya, highlighting flexible deployment, cost-effective cloud solutions, and quick ROI to support expansion, regulatory filings, and expansion into new markets.